Search Results

Over-the-Counter HCG (pregnancy) tests are for the greating individuals who, for any reason, believe they may be pregnant. This test detects HCG in urine. HCG is a hormone produced by the placenta shortly after implantation. Since HCG is present in the urine of a pregnant woman, it is an excellent marker for confirming pregnancy. Early identification is important in the management of pregnancy. This condition must be identified so that fetal exposure to potentially harmful circumstance may be minimized or eliminated. Many individuals hesitate to seek clinical confirmation of this condition (pregnancy) due to medical examination costs and appointment scheduling difficulties. This device offers an alternative to the initial office visit and will allow for more rapid initiation of pre-natal care upon confirmation tests by trained clinical technicians.

The QuickstickTM One Step HCG Pregnancy Test, like many commercially available pregnancy test kits, qualitatively measures the presence of HCG by visual color sandwich one step immunoassay technology.

Here's a breakdown of the acceptance criteria and study information for the Quickstick™ One Step HCG Pregnancy Test based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

The provided text doesn't explicitly state quantitative acceptance criteria in a traditional sense (e.g., "sensitivity must be >95%"). Instead, it compares the Quickstick™ to predicate devices and reports its performance as "substantially equivalent" and "excellent."

2. Sample Size Used for the Test Set and Data Provenance

• Clinical Sample Correlation Study:
  • Sample Size: Not explicitly stated, but clinical specimens were used.
  • Data Provenance: Not specified (e.g., country). Assumed to be retrospective or a mix of retrospective/prospective clinical samples.
• Blind Labeled Spiked Consumer Study:
  • Sample Size: 246 total tests (123 positive, 123 negative based on sensitivity/specificity results).
  • Data Provenance: Not specified (e.g., country). Appears to be a prospective study designed to mimic home use.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

• Clinical Sample Correlation Study: The ground truth was established by comparison with two predicate devices (Quidel Rapidvue and Syntron Bioresearch Be Sure Pregnancy Test). The qualifications of the personnel performing these predicate tests are not provided, nor is the number of experts involved in determining the "correlation."
• Blind Labeled Spiked Consumer Study: The "spiked" nature of this study implies that the HCG levels were known and controlled. The "ground truth" (i.e., whether HCG was present or absent) was established by the spiking process itself. No external experts were used to establish this particular ground truth, as it was artificially created.

4. Adjudication Method for the Test Set

Not applicable. The studies involved direct comparison to predicate devices or known spiked samples, rather than a process requiring expert adjudication of conflicting interpretations.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This device is a rapid diagnostic test, not an AI-assisted diagnostic tool for human readers. The "blind labeled spiked consumer study" involved "lay users" as opposed to expert readers in an MRMC context.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

Yes, in essence. The Quickstick™ is a standalone, one-step immunoassay. Its performance is evaluated on its own ability to detect hCG in urine, whether in a clinical setting ("clinical sample correlation study") or by lay users ("blind labeled spiked consumer study"). There is no separate algorithm or human-in-the-loop component beyond the user interpreting a visual color change.

7. The Type of Ground Truth Used

• Clinical Sample Correlation Study: Ground truth was established by comparing to predicate devices (Quidel Rapidvue and Syntron Bioresearch Be Sure Pregnancy Test), which are themselves established diagnostic methods for hCG. This implies that the ground truth for these predicate devices would likely be based on established clinical laboratory methods or other highly sensitive and specific assays for hCG.
• Blind Labeled Spiked Consumer Study: The ground truth was based on known HCG concentrations in spiked samples. This is a form of engineered or controlled ground truth where the presence or absence of the analyte is precisely determined by the study design.

8. The Sample Size for the Training Set

Not applicable. This device is a chemical immunoassay, not a machine learning or AI-based device that requires a training set.

9. How the Ground Truth for the Training Set Was Established

Not applicable, as there is no training set for this type of device.

Ask a specific question about this device